UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

Revolución, federalismo y violencia ritual en el gobierno indígena de Peñas (1899)

Jahrbuch für Geschichte Lateinamerikas, 2021-12, Vol.58, p.145-170

Mendieta Parada, Pilar

2021

Volltextzugriff (PDF)

Comparative genomic analysis of carbon and nitrogen assimilation mechanisms in three indigenous bioleaching bacteria: predictions and validations

BMC genomics, 2008-12, Vol.9 (1), p.581-581, Article 581

2008

Volltextzugriff (PDF)

The Role of Rituximab in Chronic Lymphocytic Leukemia Treatment and the Potential Utility of Biosimilars

The oncologist (Dayton, Ohio), 2018-03, Vol.23 (3), p.288-296

2018

Volltextzugriff (PDF)

Stoichiometric modeling of oxidation of reduced inorganic sulfur compounds (Riscs) in Acidithiobacillus thiooxidans

Biotechnology and bioengineering, 2013-08, Vol.110 (8), p.2242-2251

2013

Volltextzugriff (PDF)

Draft Genome Sequence of the Sulfobacillus thermosulfidooxidans Cutipay Strain, an Indigenous Bacterium Isolated from a Naturally Extreme Mining Environment in Northern Chile

Journal of Bacteriology, 2012-11, Vol.194 (22), p.6327-6328

2012

Volltextzugriff (PDF)

The Emergency Medical Responder: Training and Succeeding As an EMT/EMR

1st ed. 2021., 2021

Volltextzugriff (PDF)

Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Haematologica (Roma), 2016-07, Vol.101 (7), p.e295

2016

Volltextzugriff (PDF)

Disseminated tuberculosis and hemophagocytic syndrome although TB prophylaxis in patients with inflammatory bowel disease treated with Infliximab

IDCases, 2019-01, Vol.16, p.e00518, Article e00518

2019

Volltextzugriff (PDF)

Rituximab biosimilars in hematologic malignancies: the need for a real-world approach

Future oncology (London, England), 2020-09, Vol.16 (26), p.2017-2027

2020

Volltextzugriff (PDF)

Insights on the structure and stability of Licanantase: a trimeric acid-stable coiled-coil lipoprotein from Acidithiobacillus thiooxidans

PeerJ (San Francisco, CA), 2014-08, Vol.2, p.e457-e457

2014

Volltextzugriff (PDF)

Efficacy and Safety of Sublingual Fentanyl Tablets for the Management of Breakthrough Pain in Patients with Chronic Musculoskeletal Pain with Neuropathic Component: Multicenter Prospective Study

Clinical drug investigation, 2015-03, Vol.35 (3), p.169-177

2015

Volltextzugriff (PDF)

Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2021-07, Vol.35 (4), p.459-468

2021

Volltextzugriff (PDF)

The combination of CD16A/EGFR innate cell engager, AFM24, with SNK01 autologous natural killer cells in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS2675-TPS2675

2022

Volltextzugriff (PDF)

Different roles of P1 and P2 Saccharomyces cerevisiae ribosomal stalk proteins revealed by cross‐linking

Molecular microbiology, 2006-11, Vol.62 (4), p.1191-1202

2006

Volltextzugriff (PDF)

An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma

Clinical lymphoma, myeloma and leukemia, 2018-08, Vol.18 (8), p.508-518.e14

2018

Volltextzugriff (PDF)

Leveraging innate immunity with AFM24, a novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager: Interim results for the non-small cell lung cancer (NSCLC) cohort

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2533-2533

2023

Volltextzugriff (PDF)

Investigating the novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager, AFM24, to leverage the innate immune system: Interim results from the colorectal cancer (CRC) cohort

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14508-e14508

2023

Volltextzugriff (PDF)

Primary copper sulfides bioleaching vs. chloride leaching: Advantages and drawbacks

Hydrometallurgy, 2017-03, Vol.168, p.26-31

2017

Volltextzugriff (PDF)

Factors Infuencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2021-07, Vol.35 (4), p.459-468

2021

Volltextzugriff (PDF)

The bioleaching potential of a bacterial consortium

Bioresource technology, 2016-10, Vol.218, p.659-666

2016

Volltextzugriff (PDF)

Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors

Clinical cancer research, 2015-02, Vol.21 (4), p.693-700

2015

Volltextzugriff (PDF)

Acidithiobacillus thiooxidans secretome containing a newly described lipoprotein Licanantase enhances chalcopyrite bioleaching rate

Applied microbiology and biotechnology, 2011-02, Vol.89 (3), p.771-780

2011

Volltextzugriff (PDF)

Factors influencing infusion-related reactions following dosing of reference rituximab (RTX) and PF-05280586, a RTX biosimilar

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e20049-e20049

2020

Volltextzugriff (PDF)

El siglo XX mira al siglo XIX. La experiencia boliviana

Anuario del Instituto de Historia Argentina, 2015-01 (15)

2015

Volltextzugriff (PDF)

Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activation

BMC cancer, 2007-02, Vol.7 (S1), p.A2-A2, Article A2

2007

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(129)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(58)
Humans
(29)
Female
(20)
Male
(20)
Technology
(13)
Bioleaching
(12)
Aged, 80 And Over
(9)
Biotechnology & Applied Microbiology
(9)
General & Internal Medicine
(9)
Oncology
(9)
Prospective Studies
(9)
Aged
(8)
Chemistry
(8)
Physical Sciences
(8)
Adolescent
(7)
Animals
(7)
Bakterielles Laugen
(7)
Biological And Medical Sciences
(7)
Child
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Revolución, federalismo y violencia ritual en el gobierno indígena de Peñas (1899)

Comparative genomic analysis of carbon and nitrogen assimilation mechanisms in three indigenous bioleaching bacteria: predictions and validations

The Role of Rituximab in Chronic Lymphocytic Leukemia Treatment and the Potential Utility of Biosimilars

Stoichiometric modeling of oxidation of reduced inorganic sulfur compounds (Riscs) in Acidithiobacillus thiooxidans

Draft Genome Sequence of the Sulfobacillus thermosulfidooxidans Cutipay Strain, an Indigenous Bacterium Isolated from a Naturally Extreme Mining Environment in Northern Chile

The Emergency Medical Responder: Training and Succeeding As an EMT/EMR

Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Disseminated tuberculosis and hemophagocytic syndrome although TB prophylaxis in patients with inflammatory bowel disease treated with Infliximab

Rituximab biosimilars in hematologic malignancies: the need for a real-world approach

Insights on the structure and stability of Licanantase: a trimeric acid-stable coiled-coil lipoprotein from Acidithiobacillus thiooxidans

Efficacy and Safety of Sublingual Fentanyl Tablets for the Management of Breakthrough Pain in Patients with Chronic Musculoskeletal Pain with Neuropathic Component: Multicenter Prospective Study

Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar

The combination of CD16A/EGFR innate cell engager, AFM24, with SNK01 autologous natural killer cells in patients with advanced solid tumors

Different roles of P1 and P2 Saccharomyces cerevisiae ribosomal stalk proteins revealed by cross‐linking

An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma

Leveraging innate immunity with AFM24, a novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager: Interim results for the non-small cell lung cancer (NSCLC) cohort

Investigating the novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager, AFM24, to leverage the innate immune system: Interim results from the colorectal cancer (CRC) cohort

Primary copper sulfides bioleaching vs. chloride leaching: Advantages and drawbacks

Factors Infuencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar

The bioleaching potential of a bacterial consortium

Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors

Acidithiobacillus thiooxidans secretome containing a newly described lipoprotein Licanantase enhances chalcopyrite bioleaching rate

Factors influencing infusion-related reactions following dosing of reference rituximab (RTX) and PF-05280586, a RTX biosimilar

El siglo XX mira al siglo XIX. La experiencia boliviana

Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activation

Suchergebnisse filtern